ロード中...
Immunotherapy in Malignant Pleural Mesothelioma
The only registered systemic treatment for malignant pleural mesothelioma (MPM) is platinum based chemotherapy combined with pemetrexed, with or without bevacizumab. Immunotherapy did seem active in small phase II trials. In this review, we will highlight the most important immunotherapy-based resea...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7047444/ https://ncbi.nlm.nih.gov/pubmed/32154179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00187 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|